All adult patients prescribed metolazone should receive the new licensed product Xaqua®
Metolazone for Adult Patients – Bioavailability of New Licensed Product Xaqua®
Posted: Friday, February 10, 2023
Category - Medicines Update
Posted: Friday, February 10, 2023
Category - Medicines Update
All adult patients prescribed metolazone should receive the new licensed product Xaqua®
Posted: Wednesday, February 8, 2023
Category - Medicines Update
Posted: Wednesday, February 8, 2023
Category - Medicines Update
Errors involving insulin can cause serious harm to patients. A series of blogs have been published to help explain the key principles of safe insulin prescribing and administration during inpatient admission and at discharge.
The blogs cover medicines reconciliation, prescribing, administration and discharge.
Posted: Friday, February 3, 2023
Category - Formulary Update
Posted: Wednesday, February 1, 2023
Category - Medicines Update
Key points:
Increased risk of fracture, hypomagnesaemia and subacute cutaneous lupus erythematosus (SCLE) are significant adverse effects associated with PPI use that have been reported by the MHRA.
Posted: Wednesday, February 1, 2023
Category - Medicines Update
MHRA Drug Safety Update January 2023
Posted: Tuesday, January 24, 2023
Category - Medicines Update
Key Messages:
Posted: Friday, January 6, 2023
Category - Medicines Update
Posted: Friday, January 6, 2023
Category - Medicines Update
The NHSGGC Venous Thrombosis in Malignant Disease guideline has been updated
Posted: Friday, January 6, 2023
Category - Medicines Update
Key Medicine Shortages – January 2023